Dose conversion to IPX066 in advanced Parkinson's disease patients treated with carbidopa-levodopa-entacapone

被引：0

|

作者：

Hsu, A.

Khanna, S.

Kell, S.

Espay, A.

Gil, R.

Singer, C.

Gupta, S.

机构：

来源：

MOVEMENT DISORDERS | 2013年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

416

引用

收藏

页码：S149 / S149

页数：1

相关论文

共 50 条

[21] Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease
Mueller, Thomas
Moehr, Jan-Dominique
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2063 - 2071
[22] The effects of gender on adverse event reporting in Parkinson's disease patients treated with IPX066 extended-release carbidopa-levodopa capsules
Kell, S.
O'Connell, M.
Hsu, A.
Silver, D.
Elmer, L.
Gupta, S.
MOVEMENT DISORDERS, 2013, 28 : S148 - S148
[23] The effects of weight on adverse event reporting in Parkinson's disease patients treated with IPX066 extended-release carbidopa-levodopa capsules
Kell, S.
O'Connell, M.
Hsu, A.
Silver, D.
Elmer, L.
Gupta, S.
MOVEMENT DISORDERS, 2013, 28 : S146 - S147
[24] Safety analysis by higher and lower total daily dose of IPX066, an extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease
Hinson, V. K.
Stover, N.
Agarwal, P.
Khanna, S.
Kell, S.
MOVEMENT DISORDERS, 2015, 30 : S90 - S91
[25] Efficacy and Safety of IPX066, a Carbidopa-Levodopa, Extended-Release Formulation, in Early Parkinson's Disease
Pahwa, Rajesh
Elllenbogen, Aaron
Kell, Sherron
O'Conell, Martin
Hauser, Robert
Fahn, Stanley
Jankovic, Joseph
Pourcher, Emmanuelle
Hsu, Ann
Gupta, Suneel
ANNALS OF NEUROLOGY, 2013, 74 : S47 - S47
[26] Comparison of IPX066, a Novel Extended-Release Oral Carbidopa-Levodopa Formulation, to Immediate-Release Carbidopa-Levodopa in Patients with Advanced Parkinson's Disease (PD)
Hsu, Ann
Metman, Leonard Verhagen
Ellenbogen, Aaron
O'Connell, Martin
Modi, Nishit B.
Kell, Sherron
Gupta, Suneel
NEUROLOGY, 2010, 74 (09) : A350 - A350
[27] Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease
Mao, Zhongping Lily
Modi, Nishit B.
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 974 - 982
[28] Analysis of IPX066 Dosing Data in Advanced Parkinson's Disease (PD) Patients
Hsu, Ann
O'Connell, Martin
Kell, Sherron
Gupta, Suneel
NEUROLOGY, 2013, 80
[29] Extended-release carbidopa- levodopa, IPX066: Dosing and efficacy with concomitant medication use in Parkinson's disease
Gupta, S.
Khanna, S.
Kell, S.
Rubens, R.
MOVEMENT DISORDERS, 2016, 31 : S670 - S670
[30] The effects of duration of exposure on adverse event reporting in Parkinson's disease patients treated with IPX066 extended-release carbidopa-levodopa capsules
Kell, S.
Hsu, A.
O'Connell, M.
Simuni, T.
Gupta, S.
MOVEMENT DISORDERS, 2013, 28 : S148 - S149

← 1 2 3 4 5 →